cardio-oncology

Venkatesh P, Yan KL, Bravo-Jaimes K, Yang EH, Lluri G. Outcomes of malignancy in adults with congenital heart disease: a single center experience. Cardiooncology. 2022[...]

Baldassarre LA, Ganatra S, Lopez-Mattei J, Yang EH, Zaha VG, Wong TC, Ayoub C, DeCara JM, Dent S, Deswal A, Ghosh AK, Henry M, Khemka[...]

Kosaraju N, Wu P, Leng M, Bolano M, Rafique AM, Shen J, Satou N, Huchting J, Goldwater D, Aksoy O, Yang EH. Impact of frailty[...]

Kim JW, Dayah TJ, Javaid A, Monlezun DJ, Balanescu DV, Donisan T, Karimzad K, Hakeem A, Boone DL, Palaskas N, Lopez-Mattei J, Kim PY, Durand[...]

Stein-Merlob AF, Ganatra S, Yang EH. T-cell Immunotherapy and Cardiovascular Disease: Chimeric Antigen Receptor T-cell and Bispecific T-cell Engager Therapies. Heart Fail Clin. 2022 Jul;18(3):443-454.[...]

Brown SA, Yang EH, Branch M, Beavers C, Blaes A, Fradley MG, Cheng RK. Training and Career Development in Cardio-Oncology Translational and Implementation Science. Heart[...]

Vuong JT, Stein-Merlob AF, Cheng RK, Yang EH. Novel Therapeutics for Anthracycline Induced Cardiotoxicity. Front Cardiovasc Med. 2022 Apr 22;9:863314. doi: 10.3389/fcvm.2022.863314. PMID: 35528842; PMCID:[...]

Our department should excel in all missions and there are numerous examples of ways in which this is true. As I continue to learn more[...]